It has been reported that targeting Pin1 on CAFs can reduce collagen deposition, tumor growth, and CAF activation and proliferation by inhibiting lysosomal degradation of PD-L1 and ENT1 in tumor cells and activating other cancer-associated pathways [111]. This evidence concerns the gene SLC29A1 and neoplasm.